Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTX-1 Fiber in IBS-C
NCT02144753Phase 2Terminated
- Start
- Mar 2014
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) (2 arms). Primary endpoint: Composite improvement in IBS global improvement, stool frequency and consistency, and severity of abdominal pain, discomfort and bloating at 14 weeks. Started Mar 2014; status: terminated.
02
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02144753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144753.